Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity-Reference-Cited by-同舟云学术

Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity

Published:2021-12 Issue: Volume:37 Page:100913
ISSN:2352-9067
Container-title:IJC Heart & Vasculature
language:en
Short-container-title:IJC Heart & Vasculature

Author:

Navarro-Almenzar Begoña,Cerezo-Manchado Juan José,García-Candel Faustino

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS);Hindricks;European Heart J.,2020

2. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study;Chugh;Circulation,2014

3. Prevalencia de fibrilación auricular en España. Resultados del estudio OFRECE;Gómez-Doblas;Revista Española de Cardiología.,2014

4. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060;Krijthe;Eur. Heart J.,2013

5. Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS;Agewall;Revista Española de Cardiología.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Situación actual de los anticoagulantes orales de acción directa en atención primaria de España. Posicionamiento de SEMERGEN en 2023;Medicina de Familia. SEMERGEN;2024-04

2. The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis;BMC Cardiovascular Disorders;2024-01-26

3. Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data;European Journal of Clinical Pharmacology;2023-10-10

4. Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial fibrillation;IJC Heart & Vasculature;2023-10

5. An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation;Clinical and Applied Thrombosis/Hemostasis;2023-01